{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:23:41Z","timestamp":1784294621761,"version":"3.55.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T00:00:00Z","timestamp":1484611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1065892"],"award-info":[{"award-number":["APP1065892"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Council Australia"},{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP440200"],"award-info":[{"award-number":["APP440200"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1007518"],"award-info":[{"award-number":["APP1007518"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["CDF APP1082989"],"award-info":[{"award-number":["CDF APP1082989"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Services Advisory Committee"},{"DOI":"10.13039\/501100001504","name":"New Zealand Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001504","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0163509","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T18:57:14Z","timestamp":1484679434000},"page":"e0163509","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-7956","authenticated-orcid":false,"given":"Kate T.","family":"Simms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-2653","authenticated-orcid":true,"given":"Megan A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Bin","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Yuill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"ref1","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu (2014) Population screening will change (in Dutch). Bilthoven, the Netherlands"},{"key":"ref2","unstructured":"National Screening Unit (2016) Primary HPV testing consultation."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e3744","DOI":"10.1136\/bmj.e3744","article-title":"Pilot study will assess whether HPV test should replace smears to screen for cervical cancer","volume":"344","author":"J Wise","year":"2012","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"G Ronco","year":"2014","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Canfell K (2015) The Australian Example: An Integrated Approach To HPV Vaccination And Cervical Screening. HPV Today. 34 ed.","DOI":"10.1136\/bmj.h4705"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.38.8389","article-title":"Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up","volume":"30","author":"PE Castle","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref7","article-title":"Comparative Risk of High-Grade Histopathology Diagnosis After a CIN 1 Finding in Endocervical Curettage Versus Cervical Biopsy","author":"JC Gage","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"ref8","first-page":"1072","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"MJ Khan","year":"2005","journal-title":"J NatlCancer Inst"},{"key":"ref9","unstructured":"National HPV Vaccination Program Register (2015) HPV Vaccination Coverage Data."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.vaccine.2013.11.075","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey","volume":"32","author":"JML Brotherton","year":"2014","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"M Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref12","unstructured":"Australian Institute of Health and Welfare (2014) Cervical screening in Australia 2011\u20132012. Cancer series no.82. Cat. no. CAN 79. Canberra: AIHW,."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and Indigenous Australian population following a national HPV vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"MA Smith","year":"2015","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105967","article-title":"Decreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study","volume":"9","author":"C Harrison","year":"2014","journal-title":"PLoS ONE"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1473-3099(14)70841-2","article-title":"Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study","volume":"14","author":"SN Tabrizi","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2014.10.045","article-title":"Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program","volume":"33","author":"SL Osborne","year":"2015","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"H Ali","year":"2013","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/mja15.01038","article-title":"HPV vaccine impact in Australian women: ready for an HPV-based screening program","volume":"204","author":"JM Brotherton","year":"2016","journal-title":"Med J Aust"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/ijc.23633","article-title":"The predicted impact of vaccination on human papillomavirus infections in Australia","volume":"123","author":"MA Smith","year":"2008","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1016\/j.vaccine.2011.02.091","article-title":"The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia","volume":"29","author":"MA Smith","year":"2011","journal-title":"Vaccine"},{"key":"ref21","unstructured":"Medical Services Advisory Committee (2013) National Cervical Screening Program Renewal: Evidence Review (Assessment Report). MSAC Application No. 1276. Canberra: Australian Government Department of Health."},{"key":"ref22","unstructured":"Lew JB, Simms K, Smith MA, Kang YK, Xu XM, et al. (2014) National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting. MSAC application number 1276 assessment report. Canberra: Department of Health."},{"key":"ref23","unstructured":"Cancer Council Australia Cervical Cancer Prevention Guidelines Working Party (2016) Draft clinical management guidelines for the prevention of cervical cancer. Sydney: Cancer Council Australia."},{"key":"ref24","unstructured":"Programmes NHSCS (2011) NHS Cervical Screening Programme: About Cervical Screening."},{"key":"ref25","unstructured":"National Screening Unit (2008) Guidelines for Cervical Screening in New Zealand: Incorporating the management of women with abnormal cervical smears. Wellington: National Screening Unit, Ministry of Health."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1136\/bmj.e670","article-title":"Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model","volume":"344","author":"IM de Kok","year":"2012","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnci\/djn019","article-title":"Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination","volume":"100","author":"JD Goldhaber-Fiebert","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18230","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds","volume":"18","author":"HC Kitchener","year":"2014","journal-title":"Health Technol Assess"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e0151619","DOI":"10.1371\/journal.pone.0151619","article-title":"Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand","volume":"11","author":"J-B Lew","year":"2016","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"PE Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref31","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","author":"JT Cox","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref32","article-title":"Comparison of cytology, HPV DNA testing and HPV 16\/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening","author":"K Chatzistamatiou","year":"2016","journal-title":"Gynecologic oncology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.30090","article-title":"The clinical value of HPV genotyping in triage of women with high\u2010risk\u2010HPV\u2010positive self\u2010samples","volume":"139","author":"RM Ebisch","year":"2016","journal-title":"International journal of cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2468-2667(16)30019-6","article-title":"Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis","volume":"1","author":"KT Simms","year":"2016","journal-title":"The Lancet Public Health"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/ijc.30392","article-title":"Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries","volume":"139","author":"KT Simms","year":"2016","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5694\/j.1326-5377.2006.tb00661.x","article-title":"Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality","volume":"185","author":"K Canfell","year":"2006","journal-title":"Med J Aust"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/1471-2458-10-734","article-title":"Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years","volume":"10","author":"P Creighton","year":"2010","journal-title":"BMC Public Health"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.bjc.6602002","article-title":"The predicted effect of changes in cervical screening practice in the UK: results from a modelling study","volume":"91","author":"K Canfell","year":"2004","journal-title":"Br J Cancer"},{"key":"ref39","unstructured":"Canfell K, Clements M, Harris J (2008) Cost-effectiveness of proposed changes to the national cervical screening program."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Canfell K, Lew JB, Smith M, Walker R (2011) Cost-effectiveness modelling beyond MAVARIC study end-points. In: Kitchener HC, Blanks R, Cubie H, Desai M, Dunn G et al., editors. MAVARIC\u2014a comparison of automation-assisted and manual cervical screening: a randomised controlled trial Health Technology Assessment 2011; Vol 15: No 3.","DOI":"10.3310\/hta15030"},{"key":"ref41","unstructured":"Medical Services Advisory Committee (2009) Automation Assisted and Liquid Based Cytology for Cervical Cancer Screening. MSAC reference 1122, Assessment report. Canberra: Australian Government Department of Health."},{"key":"ref42","unstructured":"Medical Services Advisory Committee (2009) Human Papillomavirus Triage Test For Women With Possible or Definite Low-Grade Squamous Intraepithelial Lesions. MSAC reference 39, Assessment report. Canberra: Australian Government Department of Health."},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7086","article-title":"Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study","volume":"345","author":"R Legood","year":"2012","journal-title":"BMJ"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.vaccine.2010.12.085","article-title":"Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies","volume":"29","author":"K Canfell","year":"2011","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1471-2407-11-239","article-title":"Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study","volume":"11","author":"JF Shi","year":"2011","journal-title":"BMC Cancer"},{"key":"ref46","unstructured":"Australian Institute of Health and Welfare (AIHW) (2011) ACIM (Australian Cancer Incidence and Mortality) Books; AIHW, editor. Canberra."},{"key":"ref47","unstructured":"Australian Bureau of Statistics (2012) Deaths, Australia, 2011. Canberra: ABS."},{"key":"ref48","unstructured":"Australian Bureau of S (2002) National Health Survey, Summary of Results, Australia, 2001. Canberra: ABS."},{"key":"ref49","author":"YJ Kang","year":"2012"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1756-0500-7-109","article-title":"Testing previous model predictions against new data on human papillomavirus vaccination program outcomes","volume":"7","author":"MA Smith","year":"2014","journal-title":"BMC Res Notes"},{"key":"ref51","unstructured":"Council DoHaAae (January, 2003) Guidelines for Economic Evaluation of Environmental Health Planning and Assessment. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/91C3DED41716F10DCA257BF0001E35A5\/$File\/eee_guides1.pdf\" xlink:type=\"simple\">http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/91C3DED41716F10DCA257BF0001E35A5\/$File\/eee_guides1.pdf<\/ext-link>."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1471-0528.13071","article-title":"HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis","volume":"122","author":"L Rodriguez-Carunchio","year":"2015","journal-title":"BJOG"},{"issue":"Suppl 5","key":"ref53","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"M Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"M Arbyn","year":"2008","journal-title":"Obstetrics & Gynecology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.39219.645475.55","article-title":"Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study","volume":"335","author":"E Davey","year":"2007","journal-title":"BMJ"},{"key":"ref56","unstructured":"Australian Institute of Health and Welfare A (2012) ACIM (Australian Cancer Incidence and Mortality) Books. Canberra: AIHW."},{"key":"ref57","unstructured":"Medical Services Advisory Committee (2014) MSAC Outcomes Public Summary Document: Application No. 1276 \u2013Renewal of the National Cervical Screening Program. Canberra: Australian Goverment Department of Health."},{"key":"ref58","article-title":"Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities","year":"2005"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ygyno.2011.10.020","article-title":"HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3","volume":"124","author":"L Baandrup","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/fmb.11.161","article-title":"Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance","volume":"7","author":"JM Brotherton","year":"2012","journal-title":"Future Microbiol"},{"key":"ref61","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-114","article-title":"The prevalence of type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand","volume":"13","author":"L Simonella","year":"2013","journal-title":"BMC Infect Dis"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","article-title":"Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England","volume":"103","author":"R Howell-Jones","year":"2010","journal-title":"Br J Cancer"},{"key":"ref63","unstructured":"Australian Bureau of Statistics (2013) 3222.0 Population Projections Australia, 2012 (base) to 2101 (Series B). 26\/11\/2013 ed. Canberra"},{"key":"ref64","unstructured":"Gertig D, Smith M, Kang YJ, Canfell K, Saville M (2013) Analysis of compliance with NHMRC 2006 Guidelines in: Report on monitoring activities of the National Cervical Screening Program Safety Monitoring Committee. Cancer series 80. Cat. no. CAN 77. Canberra."},{"key":"ref65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajog.2005.01.056","article-title":"Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence","volume":"193","author":"K Elfgren","year":"2005","journal-title":"American journal of obstetrics and gynecology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"SK Kj\u00e6r","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5694\/mja14.00021","article-title":"Cervical screening rates for women vaccinated against human papillomavirus","volume":"201","author":"AC Budd","year":"2014","journal-title":"Med J Aust"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/cncr.29954","article-title":"The first comprehensive report on Indigenous Australian women&apos;s inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000\u20102011)","volume":"122","author":"LJ Whop","year":"2016","journal-title":"Cancer"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1016\/j.canep.2012.08.009","article-title":"Cervical cancer screening in Middle Eastern and Asian migrants to Australia: a record linkage study","volume":"36","author":"N Aminisani","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Cuzick J, Wheeler C (2016) Need for expanded HPV genotyping for screening. Papillomavirus Research.","DOI":"10.1016\/j.pvr.2016.05.004"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-016-1375-9","article-title":"Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use","volume":"16","author":"MA Smith","year":"2016","journal-title":"BMC health services research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0163509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T03:01:50Z","timestamp":1601348510000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0163509"}},"subtitle":[],"editor":[{"given":"Kelvin Yuen Kwong","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0163509","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,17]]}}}